A Mindfulness Based Approach to HIV Treatment Side Effects
Completed · Phase 1/Phase 2
Conditions studied: HIV Infections
In brief
We are exploring the effect that an 8 week stress reduction program based in mindfulness practices will have on the experience of medication side effects reported by HIV-infected men and women taking antiretroviral therapy.
Key facts
- Study ID
- NCT00312936
- Run by
- University of California, San Francisco
- People needed
- 76
- Starts
- 2006-07-01
- Expected to finish
- 2008-10-01
- Last updated by the study team
- 2016-05-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- HIV+ serostatus, evidenced by letter from provider, or official HIV test results.
- Currently (prior 30 days) on an acknowledged ART regimen.
- Reporting a level of side effect-related bother for the previous 30 days at or above eight (corresponding to the 40th% in another sample) on the side effect and symptom distress scale used in other studies.1, 89
- Ability to provide informed consent to be a research participant.
- English speaking.
You may not qualify if…
- Current enrollment in a behavioral coping or HIV adherence intervention research study or MBSR program. A list of such studies/programs is kept and updated throughout the study.
- Severe cognitive impairment as assessed by trained interviewer and confirmed by PI;
- Active psychosis as assessed by trained interviewer and confirmed by PI;
- Indication of active substance abuse that would interfere with capacity to participate in MBSR.
Where it is running
- University of California, San Francisco — San Francisco, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.